Literature DB >> 17891689

Seroprevalence of anti-Helicobacter pylori and anti-CagA antibodies among healthy children according to age, sex, ABO blood groups and Rh status in south-east of Iran.

Abdollah Jafarzadeh1, Jafar Ahmedi-Kahanali, Mehdi Bahrami, Zahra Taghipour.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the seroprevalence of anti-H. pylori and anti-CagA antibodies in healthy children and to investigate those relation with age, sex, ABO blood groups and Rh status.
METHODS: Serum samples from 386 children (187 males; 199 females), aged 1-15 years were tested for the presence of antibody to H. pylori and its virulence factor (CagA) by use of ELISA. ABO blood grouping were also done by hemagglutination test .
RESULTS: The overall seroprevalence of H. pylori infection was 46.6%. The prevalence of anti-H. pylori antibody was significantly (p<0.05) higher in males (51.9%) compare to females (41.7%). The prevalence of anti-CagA antibody in infected children was 72.8%. Although, the prevalence of anti-CagA antibody was higher in males (78.4%) compared to females (66.3%), but the difference was not statistically significant (p=0.07). In age subgroups of 1-5 years, 6-10 years and 11-15 years, the prevalence of anti-H. pylori was 37.6%, 46.9% and 54.9% and regarding infected-children the prevalence and the mean titer of anti-CagA antibody were 63.8%, 75.94 Uarb/ml; 75%, 63.32 Uarb/ml and 79.45%, 57.11 Uarb/ml; respectively. The seroprevalence of anti-H. pylori and anti-CagA (in infected children) were 53% and 77.3% in blood group A, 50.5% and 64.7% in blood group B, 44.4% and 62.5% in blood group AB, 41.6 % and 76.8% in blood group O, 45.9% and 73% in Rh(+) phenotype and 54.84% and 70.6% in Rh(-) phenotype, respectively. The prevalence of both antibodies did not significantly differ between ABO blood groups or Rh status. However, within blood group A, the prevalence of anti-H. pylori and anti-CagA was significantly higher in males compare to females (p<0.05).
CONCLUSION: These results showed that almost half of the children acquire H. pylori infection. Anti-CagA antibody are also common in the children. The seroprevalence of anti-H. pylori and anti-CagA antibodies were higher in males and increased with age. However, the mean titer of anti-CagA antibodies decreased with age, inversely. ABO blood groups may partly influence the prevalence of H. pylori infection, especially in male gender.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891689

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  6 in total

1.  Low frequency of cagA-positive Helicobacter pylori strains isolated from Iranian patients with MALT lymphoma.

Authors:  Amin Talebi Bezmin Abadi; Ali Ghasemzadeh; Ashraf Mohabati Mobarez
Journal:  Intern Emerg Med       Date:  2011-04-02       Impact factor: 3.397

Review 2.  Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean Region: a systematic review of prevalence and risk factors.

Authors:  Ahad Eshraghian
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

3.  Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status.

Authors:  Cosmeri Rizzato; Ikuko Kato; Martyn Plummer; Nubia Muñoz; Angelika Stein; Leen Jan van Doorn; Silvia Franceschi; Federico Canzian
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

4.  Relation between ABO blood groups and Helicobacter pylori infection in symptomatic patients.

Authors:  Mohamad Salih Jaff
Journal:  Clin Exp Gastroenterol       Date:  2011-09-19

5.  Seroprevalence of Helicobacter pylori infection and its related risk factors in symptomatic patients in southern Ethiopia.

Authors:  Endale Tadesse; Deresse Daka; Demo Yemane; Techalew Shimelis
Journal:  BMC Res Notes       Date:  2014-11-24

Review 6.  Meta-analysis of the Prevalence of Helicobacter Pylori Infection among Children and Adults of Iran.

Authors:  Mahmood Moosazadeh; Kamran B Lankarani; Mahdi Afshari
Journal:  Int J Prev Med       Date:  2016-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.